Table 2.

Clinical outcomes according to prior CEVD

	Prior CEVD (n = 253)	No prior CEVD (n = 1538)	HR (95% CI)	p value
At 30 days
MACCE	1.6 (4)	0.6 (9)	1.56 (0.94–2.58)	0.084
Death, stroke, MI	5.1 (13)	4.1 (63)	1.26 (0.69–2.29)	0.448
All-cause death	2.4 (6)	1.2 (19)	1.93 (0.77–4.84)	0.159
Cardiac death	2.4 (6)	1.2 (19)	1.93 (0.77–4.84)	0.159
Any MI	2.0 (5)	3.3 (50)	0.61 (0.24–1.53)	0.293
Any stroke	1.2 (3)	0.6 (9)	2.04 (0.55–7.53)	0.285
Any repeat revascularization	2.8 (7)	2.1 (33)	1.30 (0.58–2.95)	0.522
At 5 years
MACCE	39.1 (99)	29.9 (460)	1.41 (1.13–1.75)	0.002
Death, stroke, MI	27.3 (69)	16.7 (257)	1.73 (1.33–2.26)	< 0.001
All-cause death	19.4 (49)	11.0 (169)	1.88 (1.37–2.58)	< 0.001
Cardiac death	9.9 (25)	6.3 (97)	1.66 (1.07–2.57)	0.025
Any MI	7.9 (20)	6.2 (96)	1.32 (0.81–2.13)	0.262
Any stroke	4.3 (11)	2.6 (40)	1.74 (0.89–3.39)	0.103
Any repeat revascularization	18.2 (46)	18.6 (286)	1.05 (0.77–1.43)	0.770
At 10 years
All-cause death	41.1 (100)	24.1 (357)	1.92 (1.54–2.40)	< 0.001
At maximum follow-up
All-cause death	53.8 (121)	32.5 (442)	1.99 (1.62–2.43)	< 0.001

Data are presented as percentage (number of events). MACCE was defined as a composite of all-cause death, any stroke, any MI, or any revascularization. MACCE major adverse cardiac and cerebrovascular events, MI myocardial infarction